Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 765 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
Year : 2012  |  Volume : 16  |  Issue : 6  |  Page : 886-893

Suggested use of vaccines in diabetes

1 Department of Diabetology, Jothydev's Diabetes and Research Centre (JDC), Trivandrum, Kerala, India
2 Department of Diabetes, Metabolic Diseases and Endocrinology, Fortis Hospital, Vasant Kunj, New Delhi, India
3 Department of Medicine, JIPMER, Puducherry, India
4 Department of Diabetology, Dia Care Clinic, Ahmedabad, Gujarat, India
5 Department of Diabetology, Apollo Gleneagles Sugar and Heart Clinic, Kolkata, India
6 Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, India
7 Department of Endocrinology, Joshi Clinic & Lilavati & Bhatia Hospital, Mumbai, India
8 Department of Endocrinology, Amrita Institute of Medical Sciences, Cochin, Kerala, India
9 Department of Diabetology, Dr. Mohan's Diabetes Specialities Centre and Madras Diabetes Research Foundation, WHO Collaborating Centre for Non-Communicable Diseases Prevention and Control, Gopalapuram, Chennai, India

Correspondence Address:
Jothydev Kesavadev
CEO and Director Jothydev's Diabetes and Research Centre, Kerala
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2230-8210.102982

Rights and Permissions

Diabetes has emerged as a disease of major public health importance in India affecting the rich and the poor alike. Conventionally, comprehensive diabetes management is aimed at preventing micro and macro vascular complications. However, morbidity and mortality due to infections are also significant. In developing countries like India, the concept of adult immunization is far from reality. Recently the H1N1 pandemic has triggered the necessity for considering immunization in all age groups for the prevention of vaccine-preventable fatal infectious diseases. Considering the economics of immunization in a developing country, providing free vaccines to all adults may not be a practical solution, although the free universal immunization program for children is in existence for several decades. There is no consensus on the use of vaccines in diabetes subjects in India. However, there are some clinics offering routine pneumococcal, influenza and other vaccinations. Patients with diabetes have a deranged immune system making them more prone for infections. Hospitalization and death due to pneumococcal disease and influenza are higher in diabetes patients. They, like other healthy individuals, have a normal humoral response to vaccination with clinically significant benefits. The American Diabetes Association, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, World Health Organization, United Kingdom Guidelines and a number of other scientific organizations have well defined guidelines for vaccination in diabetes. In this article we make some suggestions for clinicians in India, regarding use of vaccines in subjects with diabetes.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded924    
    Comments [Add]    
    Cited by others 6    

Recommend this journal